Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Current Deferred Revenue (2017 - 2023)

Immuron (IMRN) posted Current Deferred Revenue of $466645.9 for Q2 2023, up 3070.44% on a QoQ basis from $14718.6 in Q4 2017.

Analysis

Immuron (IMRN) Current Deferred Revenue (2017 - 2023) Analysis & Trends

Immuron has reported Current Deferred Revenue for 2 years, with the latest figure at $466645.9 in Q2 2023.

  • On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $466645.9 in Q2 2023; TTM through Jun 2023 was $466645.9, a N/A change from a year earlier, with the FY2023 full-year figure at $470176.0, changed N/A from the prior year.
  • Current Deferred Revenue was $466645.9 for Q2 2023 at Immuron, up from $14718.6 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $466645.9 in Q2 2023, with the low at $466645.9 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn
10 Immuron 7.25 Mn -1.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 466,645.92
Dec 31, 2017 14,718.63
Sep 28, 2017 15,094.98
Aug 31, 2017 19,139.00
Jun 30, 2017 14,377.41
API Access

Immuron Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IMRN&period=max&api_key=YOUR_API_KEY